KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Adaptive Biotechnologies (ADPT) Depreciation & Amortization (IS) (2023 - 2025)

Adaptive Biotechnologies' Depreciation & Amortization (IS) history spans 3 years, with the latest figure at $4.0 million for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (IS) fell 4.43% year-over-year to $4.0 million; the TTM value through Sep 2025 reached $15.3 million, down 10.89%, while the annual FY2025 figure was $16.0 million, 8.26% down from the prior year.
  • Depreciation & Amortization (IS) for Q3 2025 was $4.0 million at Adaptive Biotechnologies, down from $4.1 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $5.8 million in Q3 2023 and bottomed at $2.8 million in Q4 2023.
  • The 3-year median for Depreciation & Amortization (IS) is $4.6 million (2024), against an average of $4.5 million.
  • The largest YoY upside for Depreciation & Amortization (IS) was 11.16% in 2024 against a maximum downside of 27.88% in 2024.
  • A 3-year view of Depreciation & Amortization (IS) shows it stood at $2.8 million in 2023, then grew by 11.16% to $3.1 million in 2024, then increased by 29.47% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Depreciation & Amortization (IS) are $4.0 million (Q3 2025), $4.1 million (Q2 2025), and $3.1 million (Q4 2024).